Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Area of Science:

• Genetics
• Oncology
• Immunology

Background:

• Diffuse large B cell lymphoma (DLBCL) is the most prevalent and aggressive subtype of non-Hodgkin lymphoma.
• Understanding the genetic basis of DLBCL is crucial for identifying individuals at risk and developing targeted therapies.

Purpose of the Study:

• To identify novel genetic susceptibility loci associated with DLBCL.
• To investigate the role of specific genetic variations in the pathogenesis of DLBCL.

Main Methods:

• A meta-analysis combining three new genome-wide association studies (GWAS) with one prior study, including 3,857 DLBCL cases and 7,666 controls of European ancestry.
• Multi-stage analysis involving additional genotyping of single nucleotide polymorphisms (SNPs) in a larger cohort (1,359 cases and 4,557 controls).

Main Results:

• Four distinct genetic loci achieved genome-wide significance, with five independent SNPs identified.
• Significant SNPs were located at 6p25.3 (EXOC2), 6p21.33 (HLA-B), 2p23.3 (NCOA1), and 8q24.21 (PVT1).
• The strongest association was observed for rs116446171 at the EXOC2 locus (P = 2.33 × 10(-21)).

Conclusions:

• The study provides substantial evidence for genetic susceptibility to DLBCL.
• Identified loci suggest that pathways involved in immune recognition and immune function are critical in DLBCL pathogenesis.